Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva wants to join Big PhRMA with an ongoing FDA Import Alert for Deficient cGMP
US FDA eases Teva headache with Ajovy approval
Teva Recalls Drug Vials, Shuts Facility Over Mold Concerns - TheStreet
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
FDA Warning Letter To Teva Highlights Need For Accurate Root Cause Investigations :: Pink Sheet
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Celltrion FDA warning causes headache for Teva's biologics ambition
QUALITY SYSTEM OBSERVATION 1 Procedures describing the handling ohvritten and oral complaints related to drug products are defic
Filling errors, counterfeit packs gain FDA's attention | Healthcare Packaging
Teva recalls one lot of leukemia med after finding particulates in vial | Fierce Pharma
Teva confirms US FDA warning letter for Hangzhou, China API plant
FDA Announces New Framework for Pharmaceutical Inspections | Packaging World
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
FDA approves Teva movement disorder treatment - Globes
Teva months from restarting production at Hungary plant banned by US FDA
Surprise US FDA inspections: Cause for alarm? | Mint
Cheap Prescription Drugs in U.S. Can Have Hidden Cost - Bloomberg
FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan | Teva, Radio, Difficult
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
